Analysts anticipate second quarter fiscal 2026 revenue of approximately $10.6 billion, down slightly year-over-year (YoY) from $10.8 billion in the prior-year period. Consensus non-GAAP earnings per share (EPS) estimate stands at $2.57, within the company's guidance range of $2.45 to $2.65.

Banco Santander reported underlying profit of €3.6 billion for Q1 2026, up 12% year-over-year (YoY) and beating analyst consensus of €3.5 billion. Total revenue rose 4% YoY to €15.1 billion, exceeding expectations of €15.0 billion, driven by 4% growth in net interest income (NII) and 6% in net fee income.

Analysts project Q1 2026 revenue of approximately $7.1 billion, implying about 48% year-over-year growth. Consensus EPS estimate stands at $0.95, reflecting over 50% growth from Q1 2025's adjusted $0.63.

TotalEnergies SE reported adjusted net income of $5.4 billion for Q1 2026, up 29% from Q1 2025 and 41% from Q4 2025. Revenue reached $49.5 billion, surpassing consensus estimates around $46.8 billion.

Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.

AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.

Shares of CRML are declining approximately 9.52% on Tuesday, April 28, 2026, falling from a prior close of $14.45 to approximately $13.08, as the initial euphoria surrounding Monday's blockbuster $835 million acquisition of European Lithium Ltd. is replaced by sober reassessment of dilution risk, deal closing complexity, and the structural sustainability of a 25% single-session price surge driven largely by retail momentum.

CRML stock surged +117% over the past 30 days, driven primarily by the announcement of a $835 million acquisition of European Lithium and a $60 million private placement. Over the past quarter, shares declined -15% amid high volatility, reflecting an initial rally on a Saudi joint venture term sheet followed by a sharp pullback.

CRML stock surged +117% over the past 30 days, driven primarily by the announcement of a $835 million acquisition of European Lithium and a $60 million private placement. Over the past quarter, shares declined -15% amid high volatility, reflecting an initial rally on a Saudi joint venture term sheet followed by a sharp pullback.

HDL stock declined approximately -6% over the past 30 days amid low trading volume and a post-earnings reaction to a Q4 2025 EPS miss. Over the past quarter, the stock fell around -19%, reflecting a broader downtrend from February highs despite year-to-date gains.

INV stock surged +87% over the past 30 days, driven by portfolio company milestones like Accelsius' product launch and strong bookings. Over the past quarter, shares rose +102%, reflecting robust Q4 2025 earnings beat and $50 million in Q1 2026 bookings across subsidiaries.

AMD stock surged +71% over the last 30 days, driven by robust demand for AI accelerators and recent analyst upgrades boosting market sentiment. Over the past quarter, shares climbed +32%, rebounding from a post-earnings selloff amid sustained AI data center growth expectations.

Shares of CLS are declining approximately 15.00% on Tuesday, April 28, 2026, falling from a prior close of approximately $325 to approximately $276, in a sharp post-earnings selloff that represents one of the most counterintuitive market reactions of the current earnings season — a 15% decline despite reporting record quarterly revenue, record adjusted EPS, and a meaningfully raised full-year outlook.

Shares of SRAD are declining approximately 10.27% on Tuesday, April 28, 2026, falling from a prior close of $13.93 to approximately $12.50, as the compound effect of Muddy Waters' short-seller allegations, Callisto Capital's corroborating accusations, multiplying class action securities fraud lawsuits, and a Q1 2026 revenue pre-announcement at the low end of investor expectations overwhelms the modest bounce that briefly stabilized the stock on April 27.

MU stock surged +47% over the last 30 days, recovering sharply from a post-earnings dip amid strong analyst support and AI-driven demand. Over the past quarter, shares rose +21%, fueled by record fiscal Q2 results but marked by volatility from profit-taking and capital expenditure concerns.

XOM stock declined 13% over the past 30 days amid falling oil prices following eased geopolitical tensions in the Middle East. Over the past quarter, shares rose 8% driven by an earlier oil price rally fueled by regional conflicts and strong upstream performance.

NVDA stock surged +31% over the past 30 days, driven by renewed investor confidence in sustained AI chip demand and positive analyst sentiment. Over the past quarter, shares rose +13%, reflecting volatility with early dips offset by strong recovery on AI catalysts like new platform launches.

NKE stock declined approximately -12% over the past 30 days, driven primarily by a post-earnings sell-off following weak fiscal Q4 sales guidance. Over the past quarter, shares fell around -27%, amid broader challenges including weakness in China and declining consumer demand in athletic apparel.

TT stock surged +18% over the past 30 days, driven by anticipation ahead of Q1 earnings and sustained momentum from prior strong results. Over the past quarter, shares climbed +23%, fueled by a Q4 earnings beat with record bookings and robust revenue growth.

CM stock rose +17% over the past 30 days, driven by positive analyst upgrades and momentum from strong quarterly results. Over the past quarter, shares gained +19%, reflecting resilient earnings beats and dividend increases amid economic uncertainty.